glp-1 drugs and gastroparesis Incidence of with Medications: Clinical Evidence GI Adverse Effects of Glucagon-Like
Description
Pancreatitis: Individuals also risk experiencing inflammation in their pancreas while they take Rybelsus
GLP-1 receptor (GLP-1R) agonists control glycemia via glucose-dependent mechanisms of action and promote weight loss in obese and diabetic individuals
[DOI] [PMC free article] [PubMed] [Google Scholar] 952.Schwenk R.W., Baumeier C., Finan B., Kluth O., Brauer C., Joost H.G
Yang, Y
If you develop symptoms suggestive of pancreatitis while taking a GLP-1 medication, immediate action is essential
Accessed 24 March 2025
